Hancock jaffe laboratories, inc. (HJLI)
Income statement / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Sep'17Jun'17
Revenues:
Total Revenues

0

0

0

31

30

41

83

31

27

38

Cost of revenues

-

-

-

-

-

-

-

-

132

0

Gross Profit

-

-

-

-

-

-

-

-

-105

38

Selling, general and administrative expenses

922

1,157

1,531

1,300

1,216

1,104

2,914

1,247

1,664

1,085

Research and development expenses

787

676

428

313

293

424

280

240

43

184

Loss from Operations

-2,298

-1,834

-1,959

-1,582

-1,798

-1,487

-3,111

-1,456

-1,812

-1,231

Other (Income) Expense:
Amortization of debt discount

-

-

-

-

0

-12

2,005

4,569

371

23

Gain on extinguishment of convertible notes payable

-

-

-

-

0

0

-43

1,524

0

0

Interest (income) expense, net

-8

-19

-13

-8

-17

-6

111

210

-

-

Interest expense, net

-

-

-

-

-

-

-

-

-75

15

Change in fair value of derivative liabilities

-

-

-

-

0

0

227

-35

4

22

Total Other (Income) Expense

-8

-19

-13

-8

-17

-19

1,933

3,291

442

17

Net Loss

-2,290

-1,814

-1,946

-1,573

-1,781

-1,468

-5,045

-4,747

-2,254

-1,248

Deemed dividend to preferred stockholders

-

-

-

-

0

0

3,180

129

116

113

Net Loss Attributable to Common Stockholders

-2,290

-1,814

-1,946

-1,573

-1,781

-1,468

-8,226

-4,876

-2,371

-1,362

Net Loss Per Basic and Diluted Common Share:

-0.12

-0.10

-0.13

-0.13

0.24

-0.13

-1.06

-0.80

-0.39

-0.22

Weighted Average Number of Common Shares Outstanding: Basic and Diluted

18,014

17,922

14,838

12,267

11,817

11,717

7,781

6,133

6,126

6,123

Royalty Income [Member]
Total Revenues

-

-

-

-

-

28

28

-

-

-

Contract Research - Related Party [Member]
Total Revenues

-

-

-

-

-

13

54

-

-

-